This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Sep;15(3):141-4.

doi: 10.1007/BF02821932.

Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia

PMID: 9819790
DOI: 10.1007/BF02821932

Editorial

Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia

M R Nowrousian. Med Oncol. 1998 Sep.

. 1998 Sep;15(3):141-4.

doi: 10.1007/BF02821932.

Author

PMID: 9819790
DOI: 10.1007/BF02821932

No abstract available

PubMed Disclaimer

Comment on

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
ten Bokkel Huinink WW, de Swart CA, van Toorn DW, Morack G, Breed WP, Hillen HF, van der Hoeven JJ, Reed NS, Fairlamb DJ, Chan SY, Godfrey KA, Kristensen GB, van Tinteren H, Ehmer B. ten Bokkel Huinink WW, et al. Med Oncol. 1998 Sep;15(3):174-82. doi: 10.1007/BF02821936. Med Oncol. 1998. PMID: 9819794 Clinical Trial.

Similar articles

Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
ten Bokkel Huinink WW, de Swart CA, van Toorn DW, Morack G, Breed WP, Hillen HF, van der Hoeven JJ, Reed NS, Fairlamb DJ, Chan SY, Godfrey KA, Kristensen GB, van Tinteren H, Ehmer B. ten Bokkel Huinink WW, et al. Med Oncol. 1998 Sep;15(3):174-82. doi: 10.1007/BF02821936. Med Oncol. 1998. PMID: 9819794 Clinical Trial.
What is the role of erythropoietin in patients with solid tumours?
Maraveyas A, Pettengell R. Maraveyas A, et al. Ann Oncol. 1998 Mar;9(3):239-41. doi: 10.1023/a:1008273032715. Ann Oncol. 1998. PMID: 9602254 Review. No abstract available.
[Use of erythropoietin in the treatment of cancer-related anemia].
Huang JX, Meng FJ. Huang JX, et al. Zhonghua Zhong Liu Za Zhi. 2011 Nov;33(11):877-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22335959 Chinese. No abstract available.
Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR. Nowrousian MR. Med Oncol. 1998 Aug;15 Suppl 1:S19-28. Med Oncol. 1998. PMID: 9785333 Review.
Management of chemotherapy-induced anemia.
Eguchi K. Eguchi K. Curr Opin Oncol. 1995 Jul;7(4):316-9. doi: 10.1097/00001622-199507000-00004. Curr Opin Oncol. 1995. PMID: 7578378 Review.

See all similar articles

References

1. J Clin Oncol. 1997 Mar;15(3):1218-34 - PubMed
1. Int J Radiat Oncol Biol Phys. 1986 Nov;12(11):2009-17 - PubMed
1. Blood. 1996 Apr 1;87(7):2675-82 - PubMed
1. Cancer. 1972 Dec;30(6):1451-6 - PubMed
1. J Clin Oncol. 1995 Jul;13(7):1623-31 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information